Manufacturer
NOVARTIS PHARMA STEIN AG
Contents
Fingolimod
Indication
Relapsing forms of multiple sclerosis to reduce frequency of clinical exacerbation & delay accumulation of physical disability.
Instruction
May be taken with or without food.
Drug interaction
Not recommended w/ class IA (eg, quinidine, procainamide) & III (eg, amiodarone, sotalol) antiarrhythmic drugs. β-blockers, heart rate lowering Ca-channel blockers (eg, verapamil or diltiazem) or other drugs that lower heart rate (eg, ivabradine or digoxin). Concomitant use w/ antineoplastic, immune-modulating or immunosuppressive therapies including corticosteroid. Switching therapy from drugs w/ long-acting immune effect eg, natalizumab, teriflunomide, mitoxantrone. Reduced efficiency during & up to 2 mth after discontinuation w/ live attenuated vaccines.
Malaysia
